Suchergebnisse - "Casasnovas, Rene-Olivier"

PubPharm (122)

1

IELSG38 : phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma

enthalten in: Haematologica | 2024

von Stathis, A. | Pirosa, M. | Orsucci, L. | +44

2

Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma : Final Analysis of the Ro-CHOP Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Camus, V. | Thieblemont, C. | Gaulard, P. | +30

3

Prognostic Value of 18F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma : A Machine-Learning Analysis from the GAINED Study

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2024

von Carlier, T. | Frécon, G. | Mateus, D. | +9

4

Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma : a LYSA study from the DESCAR-T registry

enthalten in: Blood advances | 2023

von Lemoine, J. | Bachy, E. | Cartron, G. | +21

5

Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2023

von Itti, E. | Blanc-Durand, P. | Berriolo-Riedinger, A. | +7

6

Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab

enthalten in: HemaSphere | 2023

von Rodier, C. | Kanagaratnam, L. | Morland, D. | +11

7

Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients : A LYSA group study

enthalten in: British journal of haematology | 2023

von Beldi-Ferchiou, A. | Jais, J. | Ghesquieres, H. | +19

8

High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma : Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Hermine, O. | Jiang, L. | Walewski, J. | +24

9

Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH) : A Multicenter, Open-Label, Randomized, Phase II Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Fornecker, L. | Lazarovici, J. | Aurer, I. | +23

10

Influence of Sociodemographic Determinants on the Hodgkin Lymphoma Baseline Characteristics in Long Survivors Patients Enrolled in the Prospective Phase 3 Trial AHL2011

enthalten in: Cancers | 2022

von Chevreux, S. | de Barros, S. | Laurent, C. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]